Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Iridium Communications Inc. Director's Dealing 2021

Feb 19, 2021

31757_dirs_2021-02-19_bcc9aa00-56e8-4197-8681-de64eaa4b6ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iridium Communications Inc. (IRDM)
CIK: 0001418819
Period of Report: 2021-02-17

Reporting Person: FITZPATRICK THOMAS (Director, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-17 Common Stock S 25395 $47.79 Disposed 138113 Direct
2021-02-17 Common Stock S 45195 $48.44 Disposed 92918 Direct
2021-02-17 Common Stock S 600 $49.22 Disposed 92318 Direct
2021-02-18 Common Stock M 79681 $6.08 Acquired 171999 Direct
2021-02-18 Common Stock M 90909 $6.25 Acquired 262908 Direct
2021-02-18 Common Stock S 60001 $46.59 Disposed 202907 Direct
2021-02-18 Common Stock S 110589 $47.26 Disposed 92318 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-18 Employee Stock Option (Right to Buy) $6.08 M 79681 Disposed 2023-03-01 Common Stock (79681) Direct
2021-02-18 Employee Stock Option (Right to Buy) $6.25 M 90909 Disposed 2024-01-01 Common Stock (90909) Direct

Footnotes

F1: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.15 to $48.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.15 to $49.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $49.16 to $49.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F4: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $45.99 to $46.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F5: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.99 to $47.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F6: 25% of the shares of common stock underlying the option vested and became exercisable on March 1, 2014 and quarterly thereafter in equal installments on June 1, September 1 and December 1, so that all shares of common stock underlying the option fully vested and became exercisable on March 1, 2017.

F7: 25% of the shares of common stock underlying the option vested and became exercisable on January 1, 2015 and quarterly thereafter in equal installments on April 1, July 1 and October 1, so that all shares of common stock underlying the option vested and became exercisable on January 1, 2018.